INK PharmaSolutions FZCOTM and Katalyze AI Form Strategic Global Partnership

FOR IMMEDIATE RELEASE

September 23, 2025

Dubai (UAE) and Toronto (Canada) - INK PharmaSolutions FZCOTM and Katalyze AI today announced a strategic alliance to expand access to advanced AI-driven solutions for pharmaceutical, biotech, and healthcare organizations across North America, the Middle East, and India.

Under this partnership, INK PharmaSolutions FZCOTM, led by Managing Directors Daanyaal Bandukwala and Nicole Serena, will act as Katalyze AI's distributor and strategic partner across:

Canada
United States & Mexico
Middle East (GCC + broader MENA)
India
Partnership Benefits

This collaboration brings together Katalyze AI's proprietary platforms-Digityze AI for document digitization and the Operational Data Platform (ODP) for real-time analytics-with INK PharmaSolutions' global reach and regional expertise.

The partnership is designed to:

Expand presence in highly regulated and strategically important life sciences markets.
Accelerate adoption of AI-driven solutions by leveraging INK PharmaSolutions' trusted industry relationships.
Strengthen market impact by aligning Katalyze AI's innovation with INK PharmaSolutions' ability to bridge global markets.
Create shared momentum by combining technological innovation with commercialization expertise.
Quotes

"Our collaboration with Katalyze AI reflects our shared vision to transform life sciences with innovation that is both practical and impactful."

- Daanyaal Bandukwala, Managing Director, INK PharmaSolutions FZCOTM

"This partnership is about more than distribution...it's about enabling change. Together, we're creating pathways for organizations to adopt AI confidently and effectively across regions that demand both innovation and regulatory precision."

- Nicole Serena, Managing Director, INK PharmaSolutions FZCOTM

"By combining INK PharmaSolutions' global reach and market expertise with our proprietary AI platforms, we are not only accelerating adoption across highly regulated regions, but also helping manufacturers deliver critical therapies to patients faster, with greater consistency and reliability."

- Reza Farahani, CEO, Katalyze AI

About INK PharmaSolutions FZCOTM

INK PharmaSolutions FZCOTM is a global partner to the pharmaceutical, biotech, and healthcare industries, driving innovation, advancing success, and delivering solutions that shape the future of global healthcare.

With expertise in consulting, distribution, industry education, and strategic partnerships, INK PharmaSolutions FZCOTM works across North America, Europe, the Middle East and North Africa (MENA), India, and beyond-bridging markets and supporting organizations in navigating complex regulatory and commercial landscapes.

About Katalyze AI

Katalyze AI is an AI company with proprietary models built specifically for pharmaceutical manufacturing. Its GxP-ready platform structures manufacturing data (paper-based records, PDFs, spreadsheets) into compliant, analytics-ready datasets, enabling optimized production, improved yields, and faster decision-making.

The company serves clients across North America, Europe, and Asia, including CDMOs and manufacturers of complex biologics and advanced therapeutics.

INK PharmaSolutions FZCO

Unit N o: RET-R5-190
Detached Retail R5
Plot No: JLT-PH2-RET-R5
Jumeirah Lakes Towers
Dubai
United Arab Emirates

Daanyaal Bandukwala
daanyaal@inkpharmadubai.com

Nicole Serena
Nicol@inkpharmadubai.com

INK PharmaSolutions FZCOTM️ is a global partner to the pharmaceutical, biotech, and healthcare industries. We are dedicated to driving innovation, advancing success, and delivering solutions that shape the future of global healthcare and life sciences. With expertise spanning consulting, distribution, industry education, and strategic partnerships, INK PharmaSolutions FZCO works across key regions including North America, Europe, the Middle East and North Africa (MENA), India, and beyond. Our integrated approach enables us to bridge markets, connect partners, and support organizations in navigating the complexities of an ever-evolving global landscape. By combining deep industry knowledge with a commitment to collaboration, we position our clients to stay ahead of change and achieve sustainable impact worldwide.

This release was published on openPR.